warnings
WARNINGS: For external use only. Not for ophthalmic use. Keep out of reach of children.
Lidogel
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Lidogel
- Generic name
- LIDOCAINE HCL
- Manufacturer
- PureTek Corporation
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- c7a7bf74-d67e-cc5a-e053-2a95a90a2957
- SPL ID
- f204ed3a-fdf3-ab55-e053-2995a90aa29f
- Version
- 4
- Effective date
- 2023-01-11
- Source export date
- 2026-10-12
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:43:34
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Lidogel | openfda.brand_name | |
| generic name | LIDOCAINE HCL | openfda.generic_name | |
| manufacturer name | PureTek Corporation | openfda.manufacturer_name | |
| ndc | package | 59088-466-07 | openfda.package_ndc |
| ndc | product | 59088-466 | openfda.product_ndc |
| ndc11 | package | 59088046607 | derived:openfda.package_ndc |
| rxcui | 2562183 | openfda.rxcui | |
| spl id | f204ed3a-fdf3-ab55-e053-2995a90aa29f | id | |
| spl set id | c7a7bf74-d67e-cc5a-e053-2a95a90a2957 | set_id | |
| unii | V13007Z41A | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.